Clinical Trial Update: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine [Phase 1]

View source ↗

Summary

Phase 1 open-label bioavailability study comparing pharmacokinetics of oral cladribine with intravenous cladribine. The study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Cladribine (intravenous) (cladribine)
• Cladribine (oral) (cladribine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: TERMINATED